Invivyd IVVD
NASDAQ IVVD
$0.83 +0.00 (+0.00%)
At close: Sep 4, 2026 · 4:00 PM EDT

Invivyd (IVVD) Current Leases (2022 - 2026)

Invivyd's (IVVD) quarterly Current Leases came in at $1.6 million in Q2 2026, up 46.91% on a YoY basis from $1.1 million in Q2 2025, and up 22.98% quarter-over-quarter from $1.3 million in Q4 2025.

Analysis

Invivyd (IVVD) Current Leases (2022 - 2026) Analysis & Trends

Invivyd (IVVD) has reported Current Leases for 5 consecutive years, with $1.6 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Current Leases rose 46.91% year-over-year to $1.6 million; the trailing twelve-month figure through Jun 2026 stood at $1.6 million (up 46.91% YoY), and the FY2025 full-year result was $1.3 million, up 0.77% from the prior year.
  • Current Leases climbed to $1.6 million in Q2 2026 per IVVD's latest filing, from $1.3 million in the prior quarter.
  • Across five years, Current Leases topped out at $1.6 million in Q3 2023 and bottomed at $315000.0 in Q1 2022.
  • Historically, Current Leases has averaged $1.2 million across 5 years, with a median of $1.3 million in 2024.
  • The sharpest annual moves came in 2023 and 2024: Current Leases surged 403.17% in 2023, then slumped 56.55% in 2024.
  • Over 5 years, Current Leases stood at $1.6 million in 2022, then retreated by 7.44% to $1.4 million in 2023, then slipped by 9.63% to $1.3 million in 2024, then gained by 0.77% to $1.3 million in 2025, then rose by 22.98% to $1.6 million in 2026.
  • According to Business Quant data, Current Leases over the past three periods registered $1.6 million, $1.3 million, and $1.1 million for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn -
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn -
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn -
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn 720.00 Mn
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn 11.00 Mn
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn -
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn 45.93 Mn
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn -
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn 6.27 Mn
10 Invivyd 244.65 Mn 84.57 Mn 13.01 Mn 1.62 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.62 Mn
Dec 31, 2025 1.31 Mn
Sep 30, 2025 1.10 Mn
Jun 30, 2025 1.10 Mn
Mar 31, 2025 900,000.00
Dec 31, 2024 1.30 Mn
Sep 30, 2024 1.41 Mn
Jun 30, 2024 700,000.00
Mar 31, 2024 1.13 Mn
Dec 31, 2023 1.44 Mn
Sep 30, 2023 1.64 Mn
Jun 30, 2023 1.61 Mn
Mar 31, 2023 1.59 Mn
Dec 31, 2022 1.56 Mn
Sep 30, 2022 329,000.00
Jun 30, 2022 969,000.00
Mar 31, 2022 315,000.00